Pharmacological Evaluation of Covid 19 Vaccine in Acute and Chronic Inflammatory Neuropathies

Message:
Article Type:
Review Article (دارای رتبه معتبر)
Abstract:

Neuropathic pain is a type of chronic pain that is resulted from illness, infection, or injury or is associated with these problems. Of course, neuropathic pain is not a direct result of these factors. Nerve pain is usually a complication of illness or injury. Patients with neuropathic pain suffer from burning, stabbing, and lightning pain. The neuropathic pain in some patients is persistent. Studies revealed that there is no evidence that anesthetics interfere with the immunogenic effects of the Covid-19 vaccine. In international guidelines, therapeutic interventions that require anesthesia are also prohibited after the Covid-19 vaccine is given. In the case of anesthesia but recommended, if possible, to delay surgery until complete immunity to vaccination is achieved. Some anesthetics and surgeries use anesthetics. These drugs are used to numb specific areas of the body or induce sleep to prevent pain and discomfort. Topical anesthetics and general anesthetics are two common types of these drugs. Researchers at the National Institute of Health Research of the Islamic Republic of Iran prepared a leaflet study to assess the interaction of the first group of anesthetics, namely anesthetics, on the immunogenic effects of vaccines. Studies show no studies or evidence directly assessed the influence of anesthetics on the immunogenicity of the Covid-19 vaccine. At the same time; There is also no evidence that the use of anesthetics interferes with the immunogenic effects of the Covid-19 vaccine.

Language:
English
Published:
Journal of Medicinal and Chemical Sciences, Volume:5 Issue: 4, Jul-Aug 2022
Pages:
561 to 570
magiran.com/p2610451  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!